Rating History for NewAmsterdam Pharma Co NV (NAMS) by Truist Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/18/2026 | Srikripa Devarakonda | New Coverage | Buy (N/A) |
57.00 (N/A) |
30.60 (30.82) |
0.72% | Details |
